Revenio Group Oyj
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more
Revenio Group Oyj (REVXF) - Total Liabilities
Latest total liabilities as of December 2025: $35.90 Million USD
Based on the latest financial reports, Revenio Group Oyj (REVXF) has total liabilities worth $35.90 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Revenio Group Oyj - Total Liabilities Trend (2020–2025)
This chart illustrates how Revenio Group Oyj's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Revenio Group Oyj Competitors by Total Liabilities
The table below lists competitors of Revenio Group Oyj ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hainan Haiyao Co Ltd
SHE:000566
|
China | CN¥5.47 Billion |
|
Baticim Bati Anadolu Cimento Sanayi AS
IS:BTCIM
|
Turkey | TL10.45 Billion |
|
Shenzhen Chuangyitong Technology Co.Ltd.
SHE:300991
|
China | CN¥725.84 Million |
|
Santacruz Silv
V:SCZ
|
Canada | CA$215.30 Million |
|
Anant Raj Limited
NSE:ANANTRAJ
|
India | ₹10.18 Billion |
|
Icade SA
PINK:CDMGF
|
USA | $6.20 Billion |
|
San Miguel AG
BA:SAMI
|
Argentina | AR$515.35 Billion |
|
Shanghai Smith Adhesive New
SHG:603683
|
China | CN¥1.38 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Revenio Group Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revenio Group Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revenio Group Oyj (2020–2025)
The table below shows the annual total liabilities of Revenio Group Oyj from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $35.90 Million | +6.85% |
| 2024-12-31 | $33.60 Million | -10.45% |
| 2023-12-31 | $37.52 Million | -16.95% |
| 2022-12-31 | $45.17 Million | -2.12% |
| 2021-12-31 | $46.15 Million | +3.23% |
| 2020-12-31 | $44.71 Million | -- |